Report Scope:
The report is designed to be a comprehensive business tool to report focuses on 10 selected synthetic biology companies and the key areas in the field driving the industry growth that allows these companies to succeed.

The market is divided into segments and by application/industry as follows -

By product -

  • Enabling Products.
  • Biologic Components.
  • Integrated systems
  • Enabled Products.


By Industry -

  • R&D Tools.
  • Diagnostics/Pharmaceuticals.
  • Agriculture.
  • Chemicals.
  • Energy.
  • Food & Beverages.
  • Others.


Each area is covered in detail, identifying current products in the market in the base year 2022, measuring current market size and identifying current and potential market drivers, forecasting for 2028, assessing current and potential competitors, and identifying current competitor market shares for the base year of 2022.

Report Includes:

  • 141 data tables and 33 additional tables
  • An overview of the top 10 suppliers of synthetic biology technology and the global market
  • Analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, forecasts for 2028, and projections of compound annual growth rates (CAGRs) through 2028
  • Evaluation of the current market size and revenue growth prospects specific to synthetic biology technology, accompanied by a market share analysis by test type, industry and geographic region
  • Coverage of evolving technologies, the current and future market potential, and the regulatory framework and reimbursement scenarios
  • Review of patents, the product pipeline and ESG trends related to the synthetic biology industry
  • Market share analysis of the key companies and coverage of mergers & acquisitions, joint ventures, collaborations, partnerships and other market strategies
  • Company profiles of major players within the industry, including Amyris Inc., Beyond Meat Inc., GenScript, Ginkgo Bioworks, Novozymes A/S, and Twist Biosciences.